LEGN Legend Biotech Corporation
Healthcare$29.37+4.93%ClosedMarket Cap: $5.43B
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
5.61
P/S
4.77
EV/EBITDA
-28.58
DCF Value
$-2,588.81
FCF Yield
-4.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
55.0%
Operating Margin
-11.9%
Net Margin
-22.0%
ROE
-24.9%
ROA
-15.7%
ROIC
-9.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $305.1M | 42.3% | $-49.8M | $-54.3M | $— | — |
| Q4 null | $306.4M | 59.7% | $-20.6M | $-30.8M | $— | — |
| FY null | $1.03B | 60.3% | $-136.5M | $-296.8M | $— | — |
| Q3 null | $272.3M | 57.7% | $-43.5M | $-39.7M | $— | — |
| Q2 null | $255.1M | 61.6% | $-21.9M | $-125.4M | $— | — |
| Q1 null | $195.1M | 63.4% | $-50.6M | $-100.9M | $— | — |
| Q4 null | $186.5M | 60.4% | $-74.4M | $26.3M | $— | — |
| FY null | $627.2M | 62.6% | $-303.2M | $-177.0M | $— | — |
| Q3 null | $160.2M | 65.4% | $-70.0M | $-125.3M | $— | — |
| Q2 null | $186.5M | 73.0% | $-42.0M | $-18.2M | $— | — |
| Q1 null | $94.0M | 41.8% | $-117.9M | $-59.8M | $— | — |
| Q4 2023 | $79.5M | 59.2% | $-119.8M | $-144.8M | $-0.80 | — |